(LYS4) Lyxor EuroMTS Highest - Ratings and Ratios
European Government Bonds, Short-Term Investments, Index Tracking
Description: LYS4 Lyxor EuroMTS Highest
The Lyxor UCITS EuroMTS Highest Rated Macro-Weighted Govt Bond 1-3Y DR (XETRA: LYS4) is an exchange-traded fund (ETF) that tracks the Morningstar EZN1-3 Yr Tsy Bd GR EUR index, providing investors with exposure to short-term European government bonds with high credit ratings.
As a short-term government bond ETF, LYS4 is designed to offer liquidity and relatively low volatility, making it suitable for investors seeking to manage their cash or short-term investments. The funds underlying index is constructed to reflect the performance of high-quality, short-term government bonds, which typically have lower yields compared to longer-term bonds but are considered to be less risky.
From a technical analysis perspective, the current price of 100.66 is above the 20-day simple moving average (SMA) of 100.60, indicating a slightly bullish trend. The 50-day SMA at 100.10 and 200-day SMA at 99.19 suggest a longer-term uptrend. The average true range (ATR) of 0.16 (or 0.16%) indicates relatively low volatility, which is consistent with the characteristics of short-term government bonds. Given the current technical setup, a potential target price could be the 52-week high of 100.75, while a stop-loss could be set around the 50-day SMA at 100.10.
Fundamentally, the Assets Under Management (AUM) of 265.08 million EUR indicate a moderate level of investor interest in the fund. Considering the current interest rate environment and the European Central Banks monetary policy, it is likely that short-term interest rates will remain low, supporting the demand for short-term government bonds. As a result, the funds performance is expected to remain stable, with potential for slight appreciation.
Combining both technical and fundamental analysis, a forecast for LYS4 could be a gradual increase towards the 52-week high of 100.75, driven by the ongoing demand for high-quality, short-term government bonds. However, investors should be cautious of potential rate hikes or changes in monetary policy, which could impact the funds performance. A more conservative estimate would be a stable performance around the current price, with a potential return of around 1-2% in the short term, driven by the carry from the underlying bonds.
Additional Sources for LYS4 ETF
LYS4 ETF Overview
Market Cap in USD | 313m |
Category | EUR Government Bond - Short Term |
TER | 0.16% |
IPO / Inception | 2018-11-08 |
LYS4 ETF Ratings
Growth Rating | 7.99 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 5.33 |
Analysts | - |
Fair Price Momentum | 94.12 EUR |
Fair Price DCF | - |
LYS4 Dividends
Currently no dividends paidLYS4 Growth Ratios
Growth Correlation 3m | 69.9% |
Growth Correlation 12m | 97.5% |
Growth Correlation 5y | -38.8% |
CAGR 5y | 0.01% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | 0.65 |
Alpha | -0.13 |
Beta | -0.012 |
Volatility | 1.09% |
Current Volume | 2.1k |
Average Volume 20d | 1.5k |
As of July 05, 2025, the stock is trading at EUR 100.86 with a total of 2,132 shares traded.
Over the past week, the price has changed by +0.04%, over one month by +0.10%, over three months by +0.67% and over the past year by +4.05%.
Neither. Based on ValueRay´s Analyses, Lyxor EuroMTS Highest is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 7.99 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYS4 is around 94.12 EUR . This means that LYS4 is currently overvalued and has a potential downside of -6.68%.
Lyxor EuroMTS Highest has no consensus analysts rating.
According to our own proprietary Forecast Model, LYS4 Lyxor EuroMTS Highest will be worth about 101.7 in July 2026. The stock is currently trading at 100.86. This means that the stock has a potential upside of +0.78%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 101.7 | 0.8% |